Author archives: Gus Gazzard

About Gus Gazzard

Prof. Gus Gazzard was made a Moorfields Eye Hospital Glaucoma Consultant in 2009 after training at Cambridge University, a Clinical Fellowship at Moorfields 2006-08 and a Research Fellowship with Prof Peng Khaw, running the 6-year Singapore-5FU surgical trial. He was awarded his research degree for a thesis on angle imaging and visual field loss in angle-closure glaucoma. He is Chief Investigator of the 8-year (£2.5m) multi-centre LiGHT trial of SLT and currently co-investigator on the NEI-funded ($15.2m) ‘COAST’, NIHR-funded (£2m) ‘NAMING’, ‘TRIDENT’ and ‘GLAUrious’ randomized controlled trials of glaucoma therapies. He is President of the UK & Éire Glaucoma Society, an active committee member of the European Glaucoma Society, past Director of Moorfields Glaucoma Service and current Director of Surgery at Moorfields. He has published widely on surgical trials including contributions to the Lancet, Cochrane Library and recent awards at AAO for ongoing research. He was recently elected to the 100 member ‘Glaucoma Research Society’ and voted by peers as one of the top 10 most influential ophthalmologists in the World, 2022.